(Q38365378)
Statements
Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor (English)
Yasser Perera
Maria G Silva
Silvio E Perea
scientific article published on January 2014
No description defined